
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $488.2M | $570M | $680.7M | $670.6M | $787.2M | |
Revenue Growth (YoY) | 1.79% | 16.75% | 19.43% | -1.48% | 17.39% | |
Cost of Revenues | $295.6M | $352M | $443.2M | $415.3M | $452.4M | |
Gross Profit | $192.6M | $217.9M | $237.5M | $255.3M | $334.8M | |
Gross Profit Margin | 39.46% | 38.24% | 34.89% | 38.07% | 42.53% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $3.4M | $1.7M | $5.1M | -$9M | -$2M | |
Operating Expenses | $80M | $86.8M | $94.6M | $94.1M | $102.6M | |
Operating Income | $112.6M | $131.1M | $142.9M | $161.2M | $232.2M | |
Net Interest Expenses | $21.8M | $20.1M | $24.4M | $36.9M | $68.4M | |
EBT. Incl. Unusual Items | $94.2M | $112.7M | $123.6M | $115.3M | $161.8M | |
Earnings of Discontinued Ops. | $856K | -- | -- | -- | -- | |
Income Tax Expense | $23.5M | $29.2M | $33.8M | $28.1M | $43.2M | |
Net Income to Company | $71.5M | $83.5M | $89.8M | $87.2M | $118.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $71.5M | $83.5M | $89.8M | $87.2M | $118.6M | |
Basic EPS (Cont. Ops) | $4.28 | $4.75 | $5.07 | $4.75 | $5.28 | |
Diluted EPS (Cont. Ops) | $4.26 | $4.73 | $5.04 | $4.73 | $5.26 | |
Weighted Average Basic Share | $16.7M | $17.6M | $17.7M | $18.4M | $22.5M | |
Weighted Average Diluted Share | $16.8M | $17.6M | $17.8M | $18.4M | $22.5M | |
EBITDA | $183.7M | $205.7M | $228M | $229.6M | $311.7M | |
EBIT | $115.9M | $132.8M | $148M | $152.2M | $230.2M | |
Revenue (Reported) | $488.2M | $570M | $680.7M | $670.6M | $787.2M | |
Operating Income (Reported) | $112.6M | $131.1M | $142.9M | $161.2M | $232.2M | |
Operating Income (Adjusted) | $115.9M | $132.8M | $148M | $152.2M | $230.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $191.2M | $222.9M | $218.1M | $245.7M | $298.7M | |
Revenue Growth (YoY) | 25.21% | 16.58% | -2.13% | 12.64% | 21.57% | |
Cost of Revenues | $117.8M | $144.2M | $138.5M | $138.7M | $179.7M | |
Gross Profit | $73.4M | $78.6M | $79.7M | $107M | $119M | |
Gross Profit Margin | 38.4% | 35.29% | 36.52% | 43.55% | 39.84% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $375K | $913K | $276K | -$700K | $300K | |
Operating Expenses | $21.8M | $23.8M | $24.8M | $26.5M | $31.9M | |
Operating Income | $51.6M | $54.9M | $54.9M | $80.5M | $87.1M | |
Net Interest Expenses | $5.1M | $5.3M | $7.2M | $17M | $18.1M | |
EBT. Incl. Unusual Items | $46.9M | $50.4M | $48M | $62.8M | $69.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.4M | $13.5M | $11.6M | $16.6M | $18.4M | |
Net Income to Company | $34.5M | $36.9M | $36.3M | $46.2M | $50.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $34.5M | $36.9M | $36.3M | $46.2M | $50.9M | |
Basic EPS (Cont. Ops) | $1.97 | $2.09 | $2.05 | $2.07 | $2.22 | |
Diluted EPS (Cont. Ops) | $1.96 | $2.08 | $2.04 | $2.07 | $2.21 | |
Weighted Average Basic Share | $17.5M | $17.7M | $17.8M | $22.3M | $23M | |
Weighted Average Diluted Share | $17.6M | $17.8M | $17.8M | $22.3M | $23M | |
EBITDA | $69.9M | $75.5M | $75.2M | $100.8M | $113.9M | |
EBIT | $52M | $55.8M | $55.2M | $79.8M | $87.4M | |
Revenue (Reported) | $191.2M | $222.9M | $218.1M | $245.7M | $298.7M | |
Operating Income (Reported) | $51.6M | $54.9M | $54.9M | $80.5M | $87.1M | |
Operating Income (Adjusted) | $52M | $55.8M | $55.2M | $79.8M | $87.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $526.7M | $601.7M | $675.9M | $698.2M | $840.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $320.7M | $378.5M | $437.4M | $415.5M | $493.4M | |
Gross Profit | $206M | $223.2M | $238.5M | $282.6M | $346.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $411K | $2.3M | $4.5M | -$10M | -$974K | |
Operating Expenses | $83.9M | $88.8M | $95.6M | $95.8M | $107.9M | |
Operating Income | $122.1M | $134.4M | $143M | $186.8M | $238.8M | |
Net Interest Expenses | $21.1M | $20.4M | $26.3M | $46.7M | $69.5M | |
EBT. Incl. Unusual Items | $101.4M | $116.3M | $121.1M | $130.1M | $168.3M | |
Earnings of Discontinued Ops. | $967K | -- | -- | -- | -- | |
Income Tax Expense | $25.3M | $30.3M | $31.9M | $33.1M | $45M | |
Net Income to Company | $77M | $85.9M | $89.2M | $97.1M | $123.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $77M | $85.9M | $89.2M | $97.1M | $123.3M | |
Basic EPS (Cont. Ops) | $4.48 | $4.88 | $5.02 | $4.78 | $5.42 | |
Diluted EPS (Cont. Ops) | $4.46 | $4.85 | $5.01 | $4.76 | $5.41 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $193.5M | $211.3M | $227.7M | $255.2M | $324.8M | |
EBIT | $122.5M | $136.6M | $147.4M | $176.8M | $237.8M | |
Revenue (Reported) | $526.7M | $601.7M | $675.9M | $698.2M | $840.2M | |
Operating Income (Reported) | $122.1M | $134.4M | $143M | $186.8M | $238.8M | |
Operating Income (Adjusted) | $122.5M | $136.6M | $147.4M | $176.8M | $237.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $191.2M | $222.9M | $218.1M | $245.7M | $298.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $117.8M | $144.2M | $138.5M | $138.7M | $179.7M | |
Gross Profit | $73.4M | $78.6M | $79.7M | $107M | $119M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $375K | $913K | $276K | -$700K | $300K | |
Operating Expenses | $21.8M | $23.8M | $24.8M | $26.5M | $31.9M | |
Operating Income | $51.6M | $54.9M | $54.9M | $80.5M | $87.1M | |
Net Interest Expenses | $5.1M | $5.3M | $7.2M | $17M | $18.1M | |
EBT. Incl. Unusual Items | $46.9M | $50.4M | $48M | $62.8M | $69.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.4M | $13.5M | $11.6M | $16.6M | $18.4M | |
Net Income to Company | $34.5M | $36.9M | $36.3M | $46.2M | $50.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $34.5M | $36.9M | $36.3M | $46.2M | $50.9M | |
Basic EPS (Cont. Ops) | $1.97 | $2.09 | $2.05 | $2.07 | $2.22 | |
Diluted EPS (Cont. Ops) | $1.96 | $2.08 | $2.04 | $2.07 | $2.21 | |
Weighted Average Basic Share | $17.5M | $17.7M | $17.8M | $22.3M | $23M | |
Weighted Average Diluted Share | $17.6M | $17.8M | $17.8M | $22.3M | $23M | |
EBITDA | $69.9M | $75.5M | $75.2M | $100.8M | $113.9M | |
EBIT | $52M | $55.8M | $55.2M | $79.8M | $87.4M | |
Revenue (Reported) | $191.2M | $222.9M | $218.1M | $245.7M | $298.7M | |
Operating Income (Reported) | $51.6M | $54.9M | $54.9M | $80.5M | $87.1M | |
Operating Income (Adjusted) | $52M | $55.8M | $55.2M | $79.8M | $87.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $3.5M | $5M | $6.2M | $4.9M | $7.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $56.9M | $58.5M | $62.9M | $71.8M | $76.7M | |
Inventory | $11.4M | $21M | $26.3M | $29.2M | $26.9M | |
Prepaid Expenses | $15.7M | $20.8M | $22.2M | $20.1M | $21.1M | |
Other Current Assets | $11.2M | $20.8M | $41.9M | $22.3M | $26.5M | |
Total Current Assets | $136.4M | $170.3M | $194M | $185.7M | $204.3M | |
Property Plant And Equipment | $1.6B | $1.8B | $1.8B | $2.5B | $2.7B | |
Long-Term Investments | $10.8M | $12.1M | $10.6M | $12.3M | $14.4M | |
Goodwill | $38.7M | $44.7M | $46.2M | $508.2M | $507.7M | |
Other Intangibles | $8.3M | $13.2M | $17.9M | $16.9M | $15M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $1.9B | $2.1B | $2.2B | $3.3B | $3.6B | |
Accounts Payable | $60.3M | $52.6M | $61.5M | $77.5M | $78.3M | |
Accrued Expenses | $18.1M | $20.7M | $17M | $20.4M | $18.7M | |
Current Portion Of Long-Term Debt | $189.2M | $239.6M | $223.6M | $198.4M | $222M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $6.4M | $3M | $5.6M | $14.1M | $16.1M | |
Total Current Liabilities | $329M | $376.4M | $369M | $386.4M | $419.4M | |
Long-Term Debt | $508.5M | $549.9M | $578.4M | $1.2B | $1.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.3B | $1.4B | $2.1B | $2.2B | |
Common Stock | $8.5M | $8.6M | $8.6M | $10.8M | $11.1M | |
Other Common Equity Adj | -$2.9M | $4.6M | $1.1M | -$200K | $400K | |
Common Equity | $697.1M | $774.1M | $832.8M | $1.2B | $1.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $697.1M | $774.1M | $832.8M | $1.2B | $1.4B | |
Total Liabilities and Equity | $1.9B | $2.1B | $2.2B | $3.3B | $3.6B | |
Cash and Short Terms | $3.5M | $5M | $6.2M | $4.9M | $7.9M | |
Total Debt | $697.7M | $789.5M | $802M | $1.4B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $5.6M | $5.2M | $3.1M | $1.7M | $700K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $58.1M | $51.8M | $62.3M | $68.3M | $97M | |
Inventory | $12.1M | $20M | $26M | $28M | $28.1M | |
Prepaid Expenses | $11.9M | $14.4M | $14.2M | $14.8M | $16.4M | |
Other Current Assets | $9.8M | $21.1M | $28.5M | $27.5M | $20.5M | |
Total Current Assets | $128.6M | $153M | $159.5M | $169.7M | $199.6M | |
Property Plant And Equipment | $1.6B | $1.8B | $1.9B | $2.5B | $2.8B | |
Long-Term Investments | $10.9M | $11.6M | $10.9M | $13.2M | $14.4M | |
Goodwill | $38.7M | $44.7M | $46.2M | $507.6M | $507.7M | |
Other Intangibles | $8M | $12.8M | $17.4M | $16.4M | $14.6M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2B | $2.1B | $2.2B | $3.3B | $3.7B | |
Accounts Payable | $58.2M | $30.3M | $38.2M | $63.1M | $76.6M | |
Accrued Expenses | $19.2M | $27.8M | $21.6M | $33.7M | $33.5M | |
Current Portion Of Long-Term Debt | $169.7M | $160.6M | $115.6M | $188.9M | $240.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $19.8M | $9.9M | $11.4M | $21.4M | $16.5M | |
Total Current Liabilities | $316M | $279.7M | $246.8M | $371.7M | $433.7M | |
Long-Term Debt | $508.5M | $597.9M | $656.3M | $1.2B | $1.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.3B | $1.3B | $2.1B | $2.2B | |
Common Stock | $8.5M | $8.6M | $8.7M | $10.8M | $11.2M | |
Other Common Equity Adj | -$2.6M | $1.9M | -$2M | -$1.8M | -$2.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $726.4M | $805.5M | $858.6M | $1.3B | $1.4B | |
Total Liabilities and Equity | $2B | $2.1B | $2.2B | $3.3B | $3.7B | |
Cash and Short Terms | $5.6M | $5.2M | $3.1M | $1.7M | $700K | |
Total Debt | $678.2M | $758.5M | $771.9M | $1.4B | $1.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $71.5M | $83.5M | $89.8M | $87.2M | $118.6M | |
Depreciation & Amoritzation | $67.7M | $72.9M | $80M | $77.4M | $81.5M | |
Stock-Based Compensation | $4.8M | $5.9M | $6.4M | $7.6M | $8.4M | |
Change in Accounts Receivable | -$261K | -$6.2M | $3.7M | $1M | -$13.2M | |
Change in Inventories | $1.7M | -$9.5M | -$7.8M | $300K | $3.3M | |
Cash From Operations | $158.9M | $150.5M | $158.9M | $203.5M | $239.4M | |
Capital Expenditures | $165.5M | $186.9M | $128.3M | $188.6M | $355.3M | |
Cash Acquisitions | -$22.2M | -$36.4M | -$11.8M | -$925M | $600K | |
Cash From Investing | -$181.6M | -$223M | -$136.5M | -$1.1B | -$349.9M | |
Dividends Paid (Ex Special Dividend) | -$27.2M | -$31.5M | -$35.2M | -$40M | -$54.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $89.8M | $59.5M | $49.9M | $627M | $99.5M | |
Long-Term Debt Repaid | -$53.6M | -$13.8M | -$18M | -$21.5M | -$18.5M | |
Repurchase of Common Stock | -- | -- | -- | -$28K | -- | |
Other Financing Activities | -$977K | -$1.5M | -$2.8M | -$2.5M | -$1.5M | |
Cash From Financing | $19.2M | $74M | -$21.2M | $906.6M | $113.5M | |
Beginning Cash (CF) | $7M | $3.5M | $5M | $6.2M | $4.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$3.5M | $1.5M | $1.2M | -$1.3M | $3M | |
Ending Cash (CF) | $3.5M | $5M | $6.2M | $4.9M | $7.9M | |
Levered Free Cash Flow | -$6.6M | -$36.4M | $30.6M | $14.9M | -$115.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $34.5M | $36.9M | $36.3M | $46.2M | $50.9M | |
Depreciation & Amoritzation | $17.9M | $19.7M | $20M | $21M | $26.5M | |
Stock-Based Compensation | $1.9M | $2.2M | $2.4M | $2.1M | $2.3M | |
Change in Accounts Receivable | $5.6M | $7.5M | $5.6M | $7.8M | -$13.9M | |
Change in Inventories | $1.4M | $4M | $5.4M | $4.8M | $1.6M | |
Cash From Operations | $80.4M | $69.1M | $81.7M | $97.3M | $85M | |
Capital Expenditures | $52M | $29.9M | $42.4M | $75.5M | $113.8M | |
Cash Acquisitions | -- | -- | -- | $600K | -- | |
Cash From Investing | -$51.8M | -$29.9M | -$42.7M | -$74.7M | -$113.1M | |
Dividends Paid (Ex Special Dividend) | -$7.5M | -$8.3M | -$9.5M | -$12.9M | -$14.5M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $51.1M | $79.8M | -- | -- | |
Long-Term Debt Repaid | -- | -$82.2M | -$110M | -$1.9M | -$2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.5M | -$2.8M | -$2.5M | -$1.5M | -$1M | |
Cash From Financing | -$26.5M | -$39M | -$42.2M | -$25.8M | $20.9M | |
Beginning Cash (CF) | $3.5M | $5M | $6.2M | $4.9M | $7.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.1M | $232K | -$3.1M | -$3.2M | -$7.2M | |
Ending Cash (CF) | $5.6M | $5.2M | $3.1M | $1.7M | $700K | |
Levered Free Cash Flow | $28.4M | $39.2M | $39.2M | $21.8M | -$28.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $77M | $85.9M | $89.2M | $97.1M | $123.3M | |
Depreciation & Amoritzation | $71M | $74.7M | $80.3M | $78.4M | $87M | |
Stock-Based Compensation | $5.6M | $6.3M | $6.6M | $7.3M | $8.6M | |
Change in Accounts Receivable | -$7.6M | -$4.3M | $1.8M | $3.2M | -$34.9M | |
Change in Inventories | -$841K | -$6.9M | -$6.5M | -$273K | $100K | |
Cash From Operations | $180.5M | $139.2M | $171.4M | $219.1M | $227.1M | |
Capital Expenditures | $182.3M | $164.8M | $140.8M | $221.7M | $393.6M | |
Cash Acquisitions | -$22.2M | -$36.4M | -$11.8M | -$924.4M | -- | |
Cash From Investing | -$202M | -$201.1M | -$149.2M | -$1.1B | -$388.3M | |
Dividends Paid (Ex Special Dividend) | -$28.2M | -$32.3M | -$36.4M | -$43.4M | -$55.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $81.1M | $110.6M | $78.6M | $547.9M | -- | |
Long-Term Debt Repaid | -$21.8M | -$96M | -$45.8M | $86.6M | -$18.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.5M | -$2.8M | -$2.4M | -$1.5M | -$1M | |
Cash From Financing | $23.1M | $61.5M | -$24.4M | $923M | $160.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.6M | -$367K | -$2.2M | -$1.4M | -$1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$1.8M | -$25.6M | $30.6M | -$2.5M | -$166.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $34.5M | $36.9M | $36.3M | $46.2M | $50.9M | |
Depreciation & Amoritzation | $17.9M | $19.7M | $20M | $21M | $26.5M | |
Stock-Based Compensation | $1.9M | $2.2M | $2.4M | $2.1M | $2.3M | |
Change in Accounts Receivable | $5.6M | $7.5M | $5.6M | $7.8M | -$13.9M | |
Change in Inventories | $1.4M | $4M | $5.4M | $4.8M | $1.6M | |
Cash From Operations | $80.4M | $69.1M | $81.7M | $97.3M | $85M | |
Capital Expenditures | $52M | $29.9M | $42.4M | $75.5M | $113.8M | |
Cash Acquisitions | -- | -- | -- | $600K | -- | |
Cash From Investing | -$51.8M | -$29.9M | -$42.7M | -$74.7M | -$113.1M | |
Dividends Paid (Ex Special Dividend) | -$7.5M | -$8.3M | -$9.5M | -$12.9M | -$14.5M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $51.1M | $79.8M | -- | -- | |
Long-Term Debt Repaid | -- | -$82.2M | -$110M | -$1.9M | -$2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.5M | -$2.8M | -$2.5M | -$1.5M | -$1M | |
Cash From Financing | -$26.5M | -$39M | -$42.2M | -$25.8M | $20.9M | |
Beginning Cash (CF) | $3.5M | $5M | $6.2M | $4.9M | $7.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.1M | $232K | -$3.1M | -$3.2M | -$7.2M | |
Ending Cash (CF) | $5.6M | $5.2M | $3.1M | $1.7M | $700K | |
Levered Free Cash Flow | $28.4M | $39.2M | $39.2M | $21.8M | -$28.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.